EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Baraza Cristina, Gomez [1 ]
Francisco Javier, Manero Ruiz [2 ]
Espasol Angela, Pecondon [2 ]
Mendoza Mercedes, Arenere [3 ]
Orbis Iciar, Casiamares [1 ]
Maria Jose, Rabanaque Hernandez [4 ]
机构：
[1] Hosp Univ Miguel Servet, Dept Pharm, Zaragoza, Spain
[2] Hosp Univ Miguel Servet, Rheumatol Serv, Zaragoza, Spain
[3] Hosp Clin Lozano Blesa, Dept Pharm, Zaragoza, Spain
[4] Univ Zaragoza, Fac Med, Dept Microbiol, Prevent Med & Publ Hlth, Zaragoza, Spain
来源：
ATENCION FARMACEUTICA | 2013年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Objective: To evaluate the efficacy and safety of tumor necrosis factor alpha inhibitors in Rheumatoid Arthritis (RA). Method: An observational and retrospective study conducted on patients with RA treated at a hospital between May 2000 and December 2009. We analyzed the influence of demographic and clinical factors in the effectiveness of treatments and made a comparison between them. We determined the durability of the anti-TNF-alpha agents and adverse reactions. Results: The efficacy study showed improvement in the clinical variables. The survival analysis showed no significant differences depending on the used drug or treatment line. The safety analysis revealed risk of infections. Conclusion: Infliximab, etanercept, and adalimumab are effective drugs for RA therapy, improving symptoms control and showing similar effectiveness between them.
引用
收藏
页码：150 / 157
页数：8
相关论文
共 50 条
  • [21] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Nicoletta Luciano
    Elisa Barone
    Suraj Timilsina
    M. Eric Gershwin
    Carlo Selmi
    [J]. Clinical Reviews in Allergy & Immunology, 2023, 65 : 403 - 419
  • [22] THE INFLUENCE OF TUMOUR NECROSIS FACTOR INHIBITORS ON DEMENTIA INCIDENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Vieira, Romana C. C.
    Watson, Kath
    Holmes, Clive
    McGuinness, Bernadette
    Hyrich, Kymme
    [J]. RHEUMATOLOGY, 2016, 55 : 73 - 74
  • [23] Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland
    Aaltonen, K. J.
    Joensuu, J. T.
    Pirila, L.
    Kauppi, M.
    Uutela, T.
    Varjolahti-Lehtinen, T.
    Yli-Kerttula, T.
    Isomaki, P.
    Nordstrom, D.
    Sokka, T.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 359 - 363
  • [24] PREDICTING DRUG IMMUNOGENICITY TO TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Alshehri, Mohammed
    Nair, Nisha
    Yap, Chuan Fu
    Isaacs, John D.
    Hyrich, Kimme
    Morgan, Ann W.
    Wilson, Anthony G.
    Barton, Anne
    Plant, Darren
    [J]. RHEUMATOLOGY, 2022, 61 : I13 - I13
  • [25] Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis
    Nilsson, Anna Christine
    Christensen, Anne Friesgaard
    Junker, Peter
    Lindegaard, Hanne Merete
    [J]. DANISH MEDICAL BULLETIN, 2011, 58 (04)
  • [26] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Luciano, Nicoletta
    Barone, Elisa
    Timilsina, Suraj
    Gershwin, M. Eric
    Selmi, Carlo
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 403 - 419
  • [27] Tumour necrosis factor blockade in rheumatoid arthritis
    Breedveld, FC
    [J]. CLINICAL MEDICINE, 2001, 1 (02) : 107 - 109
  • [28] Self-Reported Outcomes during Treatment with Tumour Necrosis Factor alpha Inhibitors in Patients with Rheumatoid Arthritis
    Bala, Sidona-Valentina
    Forslind, Kristina
    Mansson, Marie Edwinson
    [J]. MUSCULOSKELETAL CARE, 2010, 8 (01) : 27 - 35
  • [29] Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis
    Emery, P.
    Suh, C-H
    Weinblatt, M. E.
    Smolen, J. S.
    Keystone, E. C.
    Genovese, M.
    Vencovsky, J.
    Kay, J.
    Hong, E.
    Baek, Y.
    Ghil, J.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2020, 49 (05) : 361 - 370
  • [30] The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review
    Moots, Robert J.
    Naisbett-Groet, Barbara
    [J]. RHEUMATOLOGY, 2012, 51 (12) : 2252 - 2261
12345